Your search returned 4 results.

Results
	1.	Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. [electronic resource] by Lee, King C Shorr, Robert Rodriguez, Robert Maturo, Claudia Boteju, Lakmal W Sheldon, Adrian Producer: 20111227 In: Drug metabolism letters vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists. [electronic resource] by Konkel, Michael J Lagu, Bharat Boteju, Lakmal W Jimenez, Hermogenes Noble, Stewart Walker, Mary W Chandrasena, Gamini Blackburn, Thomas P Nikam, Sham S Wright, Jon L Kornberg, Brian E Gregory, Tracy Pugsley, Thomas A Akunne, Hyacinth Zoski, Kim Wise, Lawrence D Producer: 20060816 In: Journal of medicinal chemistry vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. [electronic resource] by Alistar, Angela Morris, Bonny B Desnoyer, Rodwige Klepin, Heidi D Hosseinzadeh, Keyanoosh Clark, Clancy Cameron, Amy Leyendecker, John D'Agostino, Ralph Topaloglu, Umit Boteju, Lakmal W Boteju, Asela R Shorr, Rob Zachar, Zuzana Bingham, Paul M Ahmed, Tamjeed Crane, Sandrine Shah, Riddhishkumar Migliano, John J Pardee, Timothy S Miller, Lance Hawkins, Gregory Jin, Guangxu Zhang, Wei Pasche, Boris Producer: 20170824 In: The Lancet. Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). [electronic resource] by Bagdanoff, Jeffrey T Donoviel, Michael S Nouraldeen, Amr Carlsen, Marianne Jessop, Theodore C Tarver, James Aleem, Saadat Dong, Li Zhang, Haiming Boteju, Lakmal Hazelwood, Jill Yan, Jack Bednarz, Mark Layek, Suman Owusu, Iris B Gopinathan, Suma Moran, Liam Lai, Zhong Kramer, Jeff Kimball, S David Yalamanchili, Padmaja Heydorn, William E Frazier, Kenny S Brooks, Barbara Brown, Philip Wilson, Alan Sonnenburg, William K Main, Alan Carson, Kenneth G Oravecz, Tamas Augeri, David J Producer: 20110124 In: Journal of medicinal chemistry vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)